Validation of the Urgency Perception Scale

被引:101
作者
Cardozo, L
Coyne, KS
Versi, E
机构
[1] Kings Coll Hosp London, London W1G 6HP, England
[2] MEDTAP Int, Bethesda, MD USA
[3] UMDNJ, New Brunswick, NJ USA
关键词
bladder; muscarinic antagonist; tolterodine; urinary urgency; perception; validation;
D O I
10.1111/j.1464-410X.2005.05345.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE To ascertain the validity and responsiveness of the Urgency Perception Scale (UPS) as an indicator of perceived urinary urgency. PATIENTS AND METHODS The UPS was developed to assess perceived urinary urgency in clinical studies evaluating the efficacy of the antimuscarinic drug, tolterodine, for treating the overactive bladder (OAB) syndrome. Secondary analyses of clinical and patient assessment data from three clinical studies of tolterodine were conducted to evaluate the UPS. Construct validity was assessed by correlations between the UPS and patient voiding diary variables and other patient assessments, including: perception of bladder condition; perception of treatment benefit; the Medical Outcomes Study Short-Form 36 health survey; the King's Health Questionnaire; the OAB Questionnaire; and the Overall Treatment Effect scale. RESULTS The UPS correlated well with the patients' perception of bladder condition (correlation coefficients-0.29 to-0.46; all P< 0.001) and with the voiding diary variables, especially incontinence episodes (-0.30 to -0.41) and pad usage (-0.25 to -0.38; all P< 0.001). An improvement in UPS score at the end of treatment was consistently reflected by significant improvements among all voiding variables. CONCLUSION Urinary urgency is a central symptom of OAB and is particularly bothersome because of its unpredictability and consequent impact on daily life. The UPS is a valid scale by which urinary urgency can be assessed subjectively, and provides a useful tool for research into urinary urgency.
引用
收藏
页码:591 / 596
页数:6
相关论文
共 19 条
[1]  
Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
[2]  
ABRAMS P, 1998, OVERACTIVE BLADDER W
[3]  
Cohen J., 1988, STAT POWER ANAL BEHA
[4]   Psychometric validation of an overactive bladder symptom and health-related quality of life questionnaire: The OAB-q [J].
Coyne, K ;
Revicki, D ;
Hunt, T ;
Corey, R ;
Stewart, W ;
Bentkover, J ;
Kurth, H ;
Abrams, P .
QUALITY OF LIFE RESEARCH, 2002, 11 (06) :563-574
[5]  
COYNE KS, IN PRESS VALUE HLTH
[6]   Noninvasive outcome measures of urinary incontinence and lower urinary tract symptoms: A multicenter study of micturition diary and pad tests [J].
Groutz, A ;
Blaivas, JG ;
Chaikin, DC ;
Resnick, NM ;
Engleman, K ;
Anzalone, D ;
Bryzinski, B ;
Wein, AJ .
JOURNAL OF UROLOGY, 2000, 164 (03) :698-701
[7]   MEASUREMENT OF HEALTH-STATUS - ASCERTAINING THE MINIMAL CLINICALLY IMPORTANT DIFFERENCE [J].
JAESCHKE, R ;
SINGER, J ;
GUYATT, GH .
CONTROLLED CLINICAL TRIALS, 1989, 10 (04) :407-415
[8]   A new questionnaire to assess the quality of life of urinary incontinent women [J].
Kelleher, CJ ;
Cardozo, LD ;
Khullar, V ;
Salvatore, S .
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 1997, 104 (12) :1374-1379
[9]  
Leidy N K, 1999, Value Health, V2, P113, DOI 10.1046/j.1524-4733.1999.02210.x
[10]   How widespread are the symptoms of an overactive bladder and how are they managed?: A population-based prevalence study [J].
Milsom, I ;
Abrams, P ;
Cardozo, L ;
Roberts, RG ;
Thüroff, J ;
Wein, AJ .
BJU INTERNATIONAL, 2001, 87 (09) :760-766